Circulating free DNA in the era of precision oncology: Pre- and post-analytical concerns

Cancer treatment has entered the era of precision medicine, where knowledge of a patient's genetic profile is used to facilitate early diagnosis, drug selection, prognosis, prediction of drug responsiveness, the onset of secondary resistance, and relapse. Circulating free DNA (cfDNA) has emerge...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jun-Liang, Liang, Zhi-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2016
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643833/
https://www.ncbi.nlm.nih.gov/pubmed/29063046
http://dx.doi.org/10.1016/j.cdtm.2016.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643833/
https://www.ncbi.nlm.nih.gov/pubmed/29063046
http://dx.doi.org/10.1016/j.cdtm.2016.12.001

Ejemplares similares